Katrina Chan

2.5k total citations
6 papers, 45 citations indexed

About

Katrina Chan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Katrina Chan has authored 6 papers receiving a total of 45 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Cancer Research. Recurrent topics in Katrina Chan's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer, Lipids, and Metabolism (2 papers) and Advanced Breast Cancer Therapies (2 papers). Katrina Chan is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer, Lipids, and Metabolism (2 papers) and Advanced Breast Cancer Therapies (2 papers). Katrina Chan collaborates with scholars based in United States. Katrina Chan's co-authors include Pingda Ren, Linda Kessler, Jeff Kucharski, Shunyou Wang, Christian Rommel, Jocelyn Staunton, Xin Guo, Katayoun A. Jessen, Yi Liu and Lian‐Sheng Li and has published in prestigious journals such as Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Katrina Chan

6 papers receiving 43 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrina Chan United States 4 40 9 8 8 7 6 45
Letitia Lensun United States 3 33 0.8× 5 0.6× 10 1.3× 3 0.4× 10 1.4× 3 42
Matthew R. Hart United States 5 24 0.6× 9 1.0× 4 0.5× 12 1.5× 6 0.9× 5 61
Rachel Newman United States 4 26 0.7× 8 0.9× 15 1.9× 20 2.5× 23 3.3× 4 59
Adil Al Hinai Netherlands 3 41 1.0× 5 0.6× 4 0.5× 4 0.5× 6 0.9× 4 69
Dan A. Landau United States 2 45 1.1× 10 1.1× 4 0.5× 4 0.5× 5 0.7× 2 54
Aicha Jeridi Germany 3 33 0.8× 6 0.7× 3 0.4× 8 1.0× 3 0.4× 7 57
Lei Qin China 5 18 0.5× 14 1.6× 5 0.6× 11 1.4× 5 0.7× 6 54
Mikhila Mahendra United States 2 34 0.8× 8 0.9× 8 1.0× 8 1.0× 8 1.1× 4 53
Sean Irwin China 4 118 3.0× 5 0.6× 5 0.6× 4 0.5× 3 0.4× 4 130
Joanna Schmidt United States 3 48 1.2× 2 0.2× 8 1.0× 4 0.5× 6 0.9× 8 60

Countries citing papers authored by Katrina Chan

Since Specialization
Citations

This map shows the geographic impact of Katrina Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrina Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrina Chan more than expected).

Fields of papers citing papers by Katrina Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrina Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrina Chan. The network helps show where Katrina Chan may publish in the future.

Co-authorship network of co-authors of Katrina Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Katrina Chan. A scholar is included among the top collaborators of Katrina Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrina Chan. Katrina Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Wang, Shunyou, Katti Jessen, Linda Kessler, et al.. (2012). Abstract 3753: Potent anti-tumor activity of mTOR kinase inhibitor in combination with anti-angiogenic agents in preclinical models of renal cell cancer. Cancer Research. 72(8_Supplement). 3753–3753. 4 indexed citations
2.
Jessen, Katti, Linda Kessler, Jeff Kucharski, et al.. (2011). Abstract A171: A potent and selective PI3K inhibitor, INK1117, targets human cancers harboring oncogenic PIK3CA mutations.. Molecular Cancer Therapeutics. 10(11_Supplement). A171–A171. 14 indexed citations
3.
Wang, Shunyou, Katti Jessen, Linda Kessler, et al.. (2011). Abstract 4486: INK128, a novel TORC1/2 inhibitor with potent oral antitumor activity in preclinical models of renal cancer. Cancer Research. 71(8_Supplement). 4486–4486. 1 indexed citations
4.
Jessen, Katayoun A., Linda Kessler, Jeff Kucharski, et al.. (2011). Abstract 4501: INK1117: A potent and orally efficacious PI3Kα-selective inhibitor for the treatment of cancer. Cancer Research. 71(8_Supplement). 4501–4501. 5 indexed citations
5.
Jessen, Katayoun A., Shunyou Wang, Xin Guo, et al.. (2010). Abstract 1668: Pharmacodynamic biomarker development for INK128, a potent and selective inhibitor of TORC1/2 for the treatment of cancer. Cancer Research. 70(8_Supplement). 1668–1668. 1 indexed citations
6.
Jessen, Katayoun A., Shunyou Wang, Linda Kessler, et al.. (2009). Abstract B148: INK128 is a potent and selective TORC1/2 inhibitor with broad oral antitumor activity. Molecular Cancer Therapeutics. 8(12_Supplement). B148–B148. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026